Authors
Loading...
Review demonstrates how prostaglandin E2 suppresses type 1 immunity while expanding regulatory cells in chronic disease, suggesting novel therapeutic targets for cancer and autoimmunity.
Paweł Kaliński (2011) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: